Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,427 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    CADTH Launches The CADTH Pharmaceutical Reviews Update

    This is a new consolidated publication that will communicate updates to CADTH's drug review process.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

    Patients who have been diagnosed with tumours or cancers after using pharmaceutical or health products may be able to pursue legal claims against manufacturers when credible scientific...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Siskinds LLP
    Siskinds LLP
Article

Carry Forward Of Health Care Spending Account Credits Amidst COVID-19 Pandemic

In connection with the COVID-19 pandemic and the many restrictions that have been placed on health related services, the CRA has recognized that members of a HCSA might not be able to use HCSA credits ...
CanadaFood, Drugs, Healthcare, Life Sciences
Bennett Jones LLP
Bennett Jones LLP
  • Video

    Causation: A Case Study With Richard Halpern (Video)

    Gluckstein Lawyers' 4th Annual Risky Business Conference: Case Updates and Practical Tips took place using a hybrid model, on November 29, 2022, from 9:00 AM to 4:00 PM.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gluckstein Lawyers
    Gluckstein Lawyers
  • Article

    CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments

    On April 15, 2025, Canada's Drug Agency (CDA) released its new five-year strategic plan, Insight to Impact 2025-2030. Formerly the Canadian Agency for Drugs and Technologies in Health (CADTH), this is the CDA's first strategic plan.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Collaboration Between The Competition Bureau And HPFB

    On January 10, 2022, the Competition Bureau and Health Canada's Health Products and Food Branch (HPFB) issued a joint notice in support of a new intra-government alliance.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Complying With Revised Regulations Under The Optometry Act

    New professional misconduct and conflict of interest regulations for optometrists came into effect earlier this year.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Miller Thomson
    Miller Thomson
  • Article

    Discipline Committee Hearings Now Broadcast On YouTube

    Over the past few months, certain health professions colleges, including the College of Chiropractors of Ontario, the College of Psychologists of Ontario and the College of Dental Hygienists...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gardiner Roberts LLP
    Gardiner Roberts LLP
  • Article

    Doctoring The Complaints Process? Procedural Fairness And Professional Discipline Legislation

    The Ontario Court of Appeal released its decision in Abdul v. Ontario College of Pharmacists, 2018 ONCA 699, assessing whether a College may institute a Registrar-initiated complaint ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    First Year Of Project Orbis Leads To 38 Approvals Of Cancer Therapies, Including 8 By Health Canada

    The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence recently published an overview of Project Orbis
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Follow-Up CBC Report Outlines Corporate Pressure Exerted By Shoppers Drug Mart

    In a follow-report released on March 14, 2024, the CBC states that it has received information from more than a dozen current and former Shoppers Drug Mart...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gardiner Roberts LLP
    Gardiner Roberts LLP
  • Article

    From Identification To Mitigation: Mastering Risks For Pharmaceutical Contracts With DiliTrust Governance

    In the complex world of pharmaceutical contracts, mistakes are costly. Every deal made and every rule imposed come with risks that can negatively impact not only financial outcomes...
    CanadaFood, Drugs, Healthcare, Life Sciences
    DiliTrust Canada Inc.
    DiliTrust Canada Inc.
  • Article

    Google’s Next Chapter In Wearable Health Tech: The Google Fitbit Air

    Google is venturing into new territory with the development of the Fitbit Air, marking a significant evolution in wearable health technology. This advancement represents Google's continued commitment to integrating sophisticated health monitoring capabilities into consumer devices. What innovations will this next-generation wearable bring to the competitive health tech market?
    CanadaFood, Drugs, Healthcare, Life Sciences
    Goodmans LLP
    Goodmans LLP
  • Article

    Health Canada's Action Plan For Non-prescription Drugs

    As part of Health Canada's initiative to update its approach to regulating self-care products, including non-prescription drugs (broadly, also including cosmetics and natural health products)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada And The Public Health Agency Of Canada Report On Red Tape Reduction Measures

    In July 2025, the federal government issued a directive to federal regulators to examine their internal process and issue a report on where efficiencies can be achieved.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Loosens Restrictions On Medical Device RFPs

    On September 4, 2013, Health Canada announced that it has revised its position on the exclusion of information describing unlicensed medical devices in responses to RFPs from Canadian healthcare facilities.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Fasken
    Fasken
  • Article

    Health Canada Provides Its Quarterly Update And PMPRB Publishes The 10th Edition Of The Meds Entry Watch Report

    On October 14, 2026, the Patented Medicine Prices Review Board (PMPRB) published the 10th edition of its annual Meds Entry Watch report. The report looks at drug approvals in 2021-2025 by Health Canada, the United States FDA and the European Medicines Agency, as well as sales information on these drugs in Q4 2024.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Publishes Guidance Documents That Address Reporting Of Adverse Reactions

    Health Canada recently published two guidance documents, effective May 23, 2018, that address the reporting of adverse reactions to marketed health products (excluding blood and blood components and cells, tissues and organs).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada: Revised Regulations And Guidances

    Separately, in Ontario, on December 12, Bill 160, the Strengthening Quality and Accountability for Patients Act, 2017, received Royal Assent.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    HHS Announces New Health Sector Cybersecurity Coordination Center

    On October 29, 2018, Deputy Secretary of the U.S. Department of Health and Human Services (HHS) Eric Hargan announced the official opening of the Health Sector Cybersecurity Coordination Center (HC3).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Dentons Canada LLP
    Dentons Canada LLP
  • Showing 321–340 of 3427 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics